Status:
COMPLETED
Prognostic Value of 18FDG PET/CT Textural Indices in HNSCC
Lead Sponsor:
University Hospital, Brest
Conditions:
Cancer of Head and Neck
Eligibility:
All Genders
18+ years
Brief Summary
Head and neck (HN) cancer is the sixth most common malignancy worldwide, with around 800,000 new cases and 320,000 deaths in 2015. These malignancies encompass cancers of the oral cavity, oropharynx, ...
Eligibility Criteria
Inclusion
- biopsy proven HSNCC
- written consent
Exclusion
- previous head and neck malignancy
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2018
Estimated Enrollment :
284 Patients enrolled
Trial Details
Trial ID
NCT03378193
Start Date
January 1 2018
End Date
March 30 2018
Last Update
July 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Brest
Brest, France, 29609